Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract

Pediatric and Developmental Pathology

Volumn 8, Issue 4, 2005, Pages 427-434

  Riedlinger, Wolfram F J ^a   Kozakewich, Harry P W ^a   Vargas, Sara O ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cervix; Immunohistochemistry; Myogenic markers; Rhabdomyosarcoma; Vagina

Indexed keywords

ACTIN; ACTIN ANTIBODY; BIOLOGICAL MARKER; DESMIN; MYOD1 PROTEIN; MYOGENIN; PROTEIN; PROTEIN ANTIBODY; PROTEIN WT1; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CASE REPORT; CELL NUCLEUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMBRYONAL RHABDOMYOSARCOMA; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MUSCLE DEVELOPMENT; MYOMETRIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SKELETAL MUSCLE; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MUSCLE, SKELETAL; RHABDOMYOSARCOMA; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; UTERUS; VAGINAL NEOPLASMS;

EID: 27744575864     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-005-0006-y     Document Type: Article

References (23)

1. Coffin CM, Dehner LP. The soft tissues. In: Stocker JT, Dehner LP, eds. Pediatric Pathology. Philadelphia: Lippincott Williams & Wilkins. 2001; p 1186.
2. Willis RA. The female genitalia. In: Willis RA, eds. The Borderland of Embryology and Pathology. Washington: Butterworths. 1962; p 98-102.
3. O'Shea PA. Myogenic tumors of soft tissue. In: Coffin CM, Dehner LP, O'Shea PA, eds. Pediatric Soft Tissue Tumors: A Clinical, Pathological, and Therapeutic Approach. Baltimore: Williams & Wilkins. 1997; p 214-253.
4. Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003;56:412-416.
5. Pediatric Oncology Resource Center. Available at: http://www.acor.org/ ped-onc/diseases/rhabdo.html. Accessed January 20, 2005.
6. Dehner LP. Female reproductive system. In: Dehner LP, eds. Pediatric Surgical Pathology. Baltimore: Williams & Wilkins. 1987; pp 752-753.
7. Hardaway CA, Graham BS, Barnette DJ, Feldman BD. Embryonal rhabdomyosarcoma presenting in an adult: a case report and discussion of immunohistochemical staining. Am J Dermatopathol 2003;25:45-52.
8. Lai R, Tian Y, An J, Zhou MW, Zou G, Li W. A comparative study on morphology and immunohistochemistry of rhabdomyosarcoma and embryonal skeletal muscles. Chin Med J (Engl) 1997;110:392-396.
9. Cui S, Hano H, Harada T, Takai S, Masui F, Ushigome S. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int 1999;49:62-68.
10. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 2000;13:988-993.
11. Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S, et al.1991The myoD gene family: nodal point during specification of the muscle cell lineageScience251761766.
12. Venuti JM, Morris JH, Vivian JL, Olson EN, Klein WH. Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol 1995;128:563-576.
13. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
14. Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988;242:405-411.
15. Rudnicki MA, Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 1995;17:203-209.
16. Dias P, Parham DM, Shapiro DN, Tapscott SJ, Houghton PJ. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res 1992;52:6431-6439.
17. Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol 2002;9:198-203.
18. Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, Coffin CM. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001;25:1150-1157.
19. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-1810.
20. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol 2001;14:595-603.
21. Wang NP, Bacchi CE, Jiang JJ, McNutt MA, Gown AM. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. Mod Pathol 1996;9:496-506.
22. Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 2002;15:1080-1086.
23. Sredni ST, Soares FA, de Caballero OL, de Camargo B. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors [letter]. Mod Pathol 2003;16:178-179.